International Biotechnology Trust (LSE:IBT) Change In Receivables : £0.08 Mil (TTM As of Feb. 2025)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Change In Receivables?

International Biotechnology Trust's change in receivables for the quarter that ended in Feb. 2025 was £0.02 Mil. It means International Biotechnology Trust's Accounts Receivable declined by £0.02 Mil from Aug. 2024 to Feb. 2025 .

International Biotechnology Trust's change in receivables for the fiscal year that ended in Aug. 2024 was £0.01 Mil. It means International Biotechnology Trust's Accounts Receivable declined by £0.01 Mil from Aug. 2023 to Aug. 2024 .

International Biotechnology Trust's Accounts Receivable for the quarter that ended in Feb. 2025 was £0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. International Biotechnology Trust's Days Sales Outstanding for the six months ended in Feb. 2025 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. International Biotechnology Trust's liquidation value for the six months ended in Feb. 2025 was £-37.37 Mil.

International Biotechnology Trust Change In Receivables Historical Data

The historical data trend for International Biotechnology Trust's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Change In Receivables Chart

International Biotechnology Trust Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Change In Receivables

Get a 7-Day Free Trial

2.46

-0.78

-0.03

0.01

International Biotechnology Trust Semi-Annual Data
	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24	Aug24	Feb25
Change In Receivables	Get a 7-Day Free Trial															-0.10	0.07	-0.04	0.06	0.02

International Biotechnology Trust Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Feb. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.08 Mil.

International Biotechnology Trust (LSE:IBT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

International Biotechnology Trust's Days Sales Outstanding for the quarter that ended in Feb. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	7.551	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, International Biotechnology Trust's accounts receivable are only considered to be worth 75% of book value:

International Biotechnology Trust's liquidation value for the quarter that ended in Feb. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4.247	-	41.614	+	0.75 * 0	+	0.5 * 0
=	-37.37

International Biotechnology Trust Change In Receivables Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 London Wall Place, London, GBR, EC2Y 5AU

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust Headlines

No Headlines